AlphAIAlphAI — Financial news for AI agents
seekingalpha.comOCT 51 min read$MCK

McKesson, CD&R in talks for $5B deal for Option Care Health: FT

McKesson and private equity firm Clayton, Dubilier & Rice are in advanced talks to acquire Option Care Health, valuing the company at over $5B, including debt. Option Care Health provides medical infusion services.

Original reporting
seekingalpha.com
Published Oct 5, 2026, 8:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 8:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefMergers & acquisitions
Primary signal
$MCK
Bullish
high confidence
Mentioned
$MCK · $OPCH
Relevance
9/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$MCKBullishHigh
01

Why it matters

The transaction values OPCH at >$5 billion, indicating a significant strategic expansion for McKesson.

02

Market read

First‑report M&A deal over $5 billion, likely to move both stocks and affect the healthcare services sector.

03

What to watch

Financing structure and integration risks may temper upside.

Relevance 9/10Novelty 9/10Timing: immediate today

Background

McKesson (MCK) and private‑equity firm Clayton, Dubilier & Rice are negotiating a takeover of Option Care Health (OPCH).

Company-level read

Ticker impact

$MCKBullishHigh confidence
Context

McKesson is in advanced talks to acquire Option Care Health in a deal valued over $5 billion.

Expected impact

likely upward pressure as market prices in the acquisition premium

Evidence & confidence

Deal size and strategic fit suggest a material positive catalyst for McKesson.

$OPCHBullishHigh confidence
Context

Option Care Health is the target of a $5 billion acquisition by McKesson.

Expected impact

likely upward pressure as investors price in the buyout premium

Evidence & confidence

Buyout announcements typically cause a sharp rise in target company shares.

Market effects

Sector

Consolidation in the medical infusion services sector could pressure peers.

Regional

U.S. healthcare services market sees increased M&A activity.

Global

Large‑cap M&A adds to overall market momentum.

Counterpoint

What could challenge this read

Deal could face regulatory scrutiny, delaying closure and weighing on MCK.

Key entities

  • Company
    McKesson Corporation

    U.S. pharmaceutical distributor and healthcare services provider.

  • Company
    Option Care Health

    Medical infusion services provider.

  • Private Equity
    Clayton, Dubilier & Rice

    Co‑owner of Option Care Health.

Read at source← All news

Also covered by

4 outlets

Related articles

OCT 7
$MCKHighAI 9/10

McKesson, private equity firm buy home infusion company, Option Care Health

McKesson Corporation and private equity firm Clayton Dubilier & Rice (CD&R) agreed to acquire Option Care Health, a home infusion company, for $5.8 billion. McKesson will invest $1.4 billion for a 49% stake, with CD&R taking 51%. The deal values Option Care Health at $32.05 per share, a 36% premium over Monday's closing price. Once completed, Option Care Health will become private and delist from Nasdaq.

managedhealthcareexecutive.com2 min
OCT 7
$LWHighAI 8/10

US Stock Movers: Lamb Weston, Option Care, Apogee Rally

Lamb Weston (LW) shares rose 11.85% after reporting Q1 sales of $1.67B and raising 2027 EBITDA guidance. Option Care (OPCH) jumped 32.8% on a $5.8B take-private deal. Apogee (APOG) gained 18.7% on strong Q2 earnings and raised FY2027 outlook. Constellation (CEG) surged 14.79% after a Google nuclear deal. RPM (RPM) rose 2.5% on record Q1 results.

hdfcsky.com2 min
OCT 7
$MCKHighAI 9/10

McKesson, CD&R to Buy Option Care for $5.8B

McKesson Corp. and private equity firm Clayton, Dubilier & Rice will acquire Option Care Health Inc. for $5.8 billion, or $32.05 per share, a 37% premium. McKesson will own 49%, with CD&R as the controlling shareholder. Option Care, a major provider of home and outpatient infusion care, will retain its management team. The deal aligns with McKesson's strategy to expand specialty care services, potentially increasing its ownership over time.

briefs.co2 min
OCT 6
$OPCHHighAI 9/10

Option Care Health (OPCH) Rockets as CD&R, McKesson Table 37% Premium Bid

Option Care Health (OPCH) surged 33% to $31.11 after announcing a $5.8B acquisition by CD&R and McKesson at a 37% premium. The deal, expected to close in 2027, values OPCH at $32.05 per share. The company will delist from Nasdaq. Hedge fund holdings fell 42% QoQ despite more funds establishing positions. Q3 earnings, due Nov 4, 2026, will not include guidance.

finance.yahoo.com2 min